ECT Electrochemotherapy for Prostate Cancer

We organize your Prostate Cancer Treatment with Dendritic Cells in Germany

Prostate Cancer Treatment with Dendritic Cells

Traditional vs. Modern Prostate Cancer Treatment in Germany

Tradional vs. Modern Prostate Cancer Treatment in Germany

Traditional prostate cancer treatment in Germany often begins with surgery or radiation therapy, depending on how advanced the cancer is. In early stages, a common option is a prostatectomy, where the prostate gland is surgically removed. This is usually recommended when the cancer is still confined to the prostate and offers a good chance of a cure. Radiation therapy, on the other hand, uses high-energy rays to kill cancer cells and is often an alternative for patients who cannot undergo surgery.

Chemotherapy is another widely used method, especially for advanced prostate cancer. It involves the use of drugs to destroy rapidly growing cancer cells. However, chemotherapy can come with side effects like fatigue, nausea, and a weakened immune system. While it can help shrink tumors and relieve symptoms, it is not typically a cure.

Treatment Plan:

Based on the stage and your overall health, your doctor will discuss prostate cancer treatment possibilities. These may include:

The Shift Toward Modern Immunotherapy for Cancer

Table of Contents

Moreover, in recent years, there has been a growing interest in advanced therapies that support the body’s own defense systems. One such promising option is prostate cancer treatment in Germany using immunotherapy. Unlike chemotherapy, which attacks both healthy and cancerous cells, immunotherapy aims to boost the immune system’s ability to fight cancer more precisely.

What is dendritic cell therapy for prostate cancer?

However, Prostate Cancer treatment with Dendritic Cells is gaining attention. It involves collecting a patient’s immune cells, activating them in a lab, and reintroducing them into the body. Hence, these cells then help the immune system identify and destroy cancer cells more effectively. This method is less invasive and has fewer side effects, making it suitable for many patients.

As a result, specialized clinics in Germany are now offering Prostate Cancer treatment with Dendritic Cells as part of a more modern and holistic cancer treatment approach. This innovative method gives patients new hope and a personalized path toward healing and GermanyHealth is your partner.

How does dendritic cell vaccine work for prostate cancer?

Can I combine Dendritic Cell Therapy with Priming and ECT Electrochemotherapy?

Combining Dendritic Cell Therapy + Priming + ECT Electrochemotherapy for Prostate Cancer

Dendritic cell therapy (DCT) and electrochemotherapy (ECT) are two innovative treatments that can be even more powerful when used together against prostate cancer.

However, DCT uses special immune cells (dendritic cells) to “teach” your immune system to find and attack cancer. ECT, on the other hand, uses tiny electric pulses to help chemotherapy drugs enter cancer cells more effectively, destroying tumors at the site.

When combined, these treatments work as a team — ECT kills cancer cells and releases tumor signals, while DCT boosts the immune system to recognize and attack remaining cancer.

Advantages of combining Dendritic Cell Therapy + Priming + Electrochemotherapy:

  • Stronger immune activation – ECT helps release cancer signals that DCT can use to train the immune system.
  • Better tumor control – The combo can reduce tumor size and slow growth more effectively.
  • Targets both local and hidden cancer – ECT hits the visible tumor, while DCT helps find invisible or distant cancer cells.
  • Lower side effects – Both treatments are generally well-tolerated and can avoid harsh chemotherapy.
  • Promising option for advanced or resistant cancer – Especially helpful when standard treatments stop working.

This combo offers hope for more personalized and effective prostate cancer care.

Step 1:

Priming is a Short-term immunotherapy with the immuno-oncological intraprostatic administration of Impilimumab/Yervoy™ in combination with Docetaxel for the treatment of prostate cancer.

The priming is under general anesthesia and with one overnight stay in the clinic. 

 

Step 2:

Electrochemotherapy (ECT) for prostate cancer is a treatment that combines chemotherapy with electrical pulses to destroy cancer cells more effectively.

Step-by-Step:

  • Chemotherapy Drug is Given:

    •  Pembrolizumab/Keytruda™ .

    • The drug is injected directly into the tumor.

  • Electric Pulses are Applied:

    • Small, controlled electric pulses are delivered to the tumor area using thin electrodes (probes).

    • These pulses temporarily open pores in the cancer cell membranes (a process called electroporation).

  • Drug Enters Cancer Cells More Easily:

    • With the pores open, the chemo drug enters the cells much more effectively—up to 1000 times more than usual.

    • Once inside, the drug becomes much more toxic to cancer cells, leading to their death.

ECT is a targeted way to boost chemo effectiveness while minimizing side effects, making it a smart tool in advanced or complex prostate cancer cases.

Step 3:

Third part of the Pembrolizumab/Keytruda™ treatment: 

The third part of the advanced immuno-oncological therapy using the drug Pembrolizumab /Keytruda™ what is usually administered 3 – 4 weeks after the first inpatient treatment (ECT). 

What is Priming and ECT Electrochemotherapy?

How does it work?

Step 1:

Priming is a Short-term immunotherapy with the immuno-oncological intraprostatic administration of Impilimumab/Yervoy™ in combination with Docetaxel for the treatment of prostate cancer.

The priming is under general anesthesia and with one overnight stay in the clinic. 

 

Step 2:

Electrochemotherapy (ECT) for prostate cancer is a treatment that combines chemotherapy with electrical pulses to destroy cancer cells more effectively.

Step-by-Step:

  • Chemotherapy Drug is Given:

    •  Pembrolizumab/Keytruda™ .

    • The drug is injected directly into the tumor.

  • Electric Pulses are Applied:

    • Small, controlled electric pulses are delivered to the tumor area using thin electrodes (probes).

    • These pulses temporarily open pores in the cancer cell membranes (a process called electroporation).

  • Drug Enters Cancer Cells More Easily:

    • With the pores open, the chemo drug enters the cells much more effectively—up to 1000 times more than usual.

    • Once inside, the drug becomes much more toxic to cancer cells, leading to their death.

ECT is a targeted way to boost chemo effectiveness while minimizing side effects, making it a smart tool in advanced or complex prostate cancer cases.

Step 3:

Third part of the Pembrolizumab/Keytruda™ treatment: 

The third part of the advanced immuno-oncological therapy using the drug Pembrolizumab /Keytruda™ what is usually administered 3 – 4 weeks after the first inpatient treatment (ECT). 

Clinical Trials of Dendritic Cell Vaccination & DC Vaccine:

Conclusion

Prostate Cancer treatment with Dendritic Cells offers a promising by helping the immune system recognize and attack cancer cells more effectively.

When combined with other immunotherapies, such as checkpoint inhibitors, the effect can be stronger and more efficient, as the drug and therapies help remove the “brakes” that stop immune cells from working

Adding the Priming with Impilimumab/Yervoy™ and ECT electrochemotherapy with Keytrudawhich uses electric pulses to make cancer cells more sensitive to chemotherapy can further improve results by breaking down the tumor and releasing cancer signals that alert the immune system.

Hence, together these therapies create a powerful combination: dendritic cells train the immune system, checkpoint inhibitors boost the immune attack, and electrochemotherapy helps expose the tumor.

As a result, this multi-step approach may slow cancer growth, improve survival, and reduce side effects compared to traditional treatments. 

Still questions?

Every month 20+ patients booking from across the world their Dendritic Cell Therapy at GermanyHealth

When you can start dendritic cell therapy (DC therapy) depends on several key factors, including your diagnosis, eligibility and location.

Here’s how to determine your timeline:

The oncologist or immunotherapy specialist needs to determine if you're a good candidate, based on:

  • Tumor type and stage

  • Prior treatments

  • Overall health

Basically you get your dendritic cell therapy 10-14 days after you had contact us.

“The success rate of immunotherapy depends strongly on the type and stage of your cancer, as well as your overall health and how your immune system responds. However, in some cancers like melanoma, non-small cell lung cancer, glioblastoma, pancreatic cancer, proste cancer or certain lymphomas, immunotherapy has shown significant success—even complete remission in some cases.

For other cancers, it may be used to slow progression, improve quality of life, or support other treatments. That’s why we offer personalized evaluations to determine if this therapy is likely to be effective in your specific case.

Hence the goal of GermanyHealth is always to find the best approach for your unique condition.”

“Unlike chemotherapy and radiation, which attack both cancer and healthy cells, immunotherapy works by training your own immune system to recognize and destroy cancer cells specifically. Hence, this means fewer side effects in many cases and a more natural, long-term defense against cancer.

Chemotherapy and radiation are still effective and widely used, especially in fast-growing tumors, but immunotherapy can offer a more targeted approach—especially for cancers that are resistant to traditional treatments.

Though, in many cases, we use them together to maximize results, depending on what’s best for your individual case.”

“Yes, like all medical treatments, dendritic cell therapy and other immunotherapies can have side effects—but they are generally much milder compared to chemotherapy or radiation.

Most patients experience only mild flu-like symptoms such as fatigue, fever, or soreness at the injection site.

These effects usually go away within a day or two. Serious side effects are rare, especially with dendritic cell therapy, because it works with your body’s natural immune system. However, we closely monitor every patient and personalize the treatment to minimize risks as much as possible.”

  • Side effects exist but are typically mild.

  • Dendritic cell therapy is known for being well-tolerated.

  • Monitoring and personalization reduce risks.

  • Compared to chemo or radiation, the body handles it much better.

Dendritic cell (DC) therapy is generally considered safe and has shown scientific validation, especially in cancer treatment. Here's a breakdown:

  • Hundreds of clinical trials globally are testing DC therapies for:

    • Melanoma

    • Glioblastoma

    • Renal cell carcinoma

    • Breast cancer

    • Pancreatic cancer

    • Prostate cancer

    • Brain tumors

    • Ovarian cancer, and lung cancers

  • Some trials combine DC therapy with checkpoint inhibitors or chemotherapy to enhance effect.

  • Dendritic cell therapy generally ranges  to €33,000, depending on the vaccine complexity and additional services .

  • Combined Immunotherapy of Dendritic cell vaccination and viro-therapy with hyperthermia starts at €85.000 to €280.000 Euro
  • Checkpoint inhibitors (e.g., pembrolizumab, nivolumab), often used in advanced cancers, can total around €235,000–€320,000 for a full course .

  • CAR‑T cell therapies (like Kymriah/Yescarta) are priced at €485,000–€585,000 (But is not without any risks!)

Seeking dendritic cell therapy in Mexico is becoming more common, especially among international patients looking for alternative or integrative treatments. However, not all clinics are created equal, and safety, licensing, and quality control can vary greatly. Here's what I recommend if you're seriously considering a clinic in Mexico:

  1. Medical Licensing & Accreditation

    • Ensure the clinic is licensed by COFEPRIS (Mexico’s equivalent of the FDA).

    • Ask whether their lab is GMP-certified (Good Manufacturing Practice).

    • Check for affiliations with international medical bodies or universities.

  2. Physician Credentials

    • Confirm that the doctors are board-certified and trained in oncology or immunotherapy.

    • Ask about their experience specifically with dendritic cell therapy.

  3. Treatment Transparency

    • A reputable clinic should explain:

      • How the dendritic cells are prepared (e.g., in-house or outsourced)

      • Whether your cells are used (autologous) or donor-derived

      • The full treatment plan, expected outcomes, and follow-up care

    • They should provide a written cost estimate and not pressure you.

  4. Scientific Basis

    • The clinic should use validated protocols supported by research.

    • Ask for clinical outcome data if available (remission rates, safety record).

  5. Infection Control & Safety

    • The facility should follow strict hygiene protocols.

    • Ask if they have hospital backup or ICU partnerships in case of complications.


⚠️ Red Flags:

  • Vague treatment descriptions like “immune boosting” without medical detail

  • No lab or physician info on the website

  • Claims of 100% success or “miracle cures”

  • Refusal to provide licenses, protocols, or lab certification

  • Asking for large payments upfront without documentation


🇲🇽 Is It Safe?

Some clinics in Mexico are safe and well-run, especially those in places like Tijuana, Cancun, or Mexico City, where medical tourism is strong.

However, others operate without proper oversight, and there are cases of unproven or unregulated therapies being marketed aggressively.

If you do your due diligence—and ideally consult with your own doctor or an independent advisor—it can be a viable option. But do not rely on advertising alone.

Ask questions, get documentation, and compare with options in countries like Germany, where regulation is stricter.


Go to our contact site and leave your initials there and upload your reports.

Find the best clinic for Prostate Cancer treatment with Dendritic Cells in Germany

GermanyHealth is a reputable health service organization that has been serving individuals, business and ministries for over 20 years. Based in Munich, Germany, the company specializes in providing comprehensive health solutions, ranging from medical consultations to cancer treatment programs. Our services are designed to cater to international clients, offering a seamless experience in accessing top-tier healthcare services.

1. Specialized Medical Treatments:

GermanyHealth offers access to top hospitals and clinics for a wide range of advanced medical procedures. Some of their areas of expertise include:

  • Cancer treatment including innovative immunotherapies like dendritic cell therapy.

2. Personalized Patient Assistance:

One of their standout features is their medical concierge services, offering personalized support throughout the treatment process. This includes:

  • Transportations
  • Organizing accommodation close to medical facilities
  • Guidance, onside service and translators

3. Access to Renowned Medical Institutions:

Through their network, GermanyHealth helps patients access leading medical institutions known for cutting-edge technology and skilled professionals, often offering treatments not readily available in other countries.

Our services are designed to cater to international clients, offering a seamless experience in accessing top-tier healthcare services.

Hence, we have partnerships with leading hospitals, clinics, and experienced doctors across Germany ensuring that clients receive the highest standard of care. 

With a track record of excellence and a commitment to innovation, GermanyHealth continues to set the standard for healthcare services, making it a trusted partner.

Overall, GermanyHealth is best known for streamlining the healthcare process for international patients. Hence, we cater to a diverse range of medical needs while ensuring that patients have the best access to world-class healthcare such as Prostate Cancer treatment with Dendritic Cells in Germany and immunotherapy for cancer in Germany.